Forecast: Energy Consumption in Manufacture of Medicines in China

The energy consumption in the manufacture of medicines in China stood at 2.38 ten million tons of standard coal equivalent in 2023. Over the past decade, this industry has displayed varied growth patterns. From 2013 to 2019, the sector experienced sporadic growth and declines, peaking in 2016, then slightly dropping in the succeeding years. The trend shifted positively from 2020, leading to a continuous upward trajectory. The last two years witnessed a growth of 1.8% in 2022 and 1.71% in 2023. Over the past five years, the compound annual growth rate (CAGR) has been 1.78%. For the next five years, the forecasted CAGR is 1.14%, suggesting steady but moderate growth estimated at approximately 5.83% by 2028.

Future trends to watch for:

• Emphasis on sustainability and energy efficiency may influence energy consumption trends.
• Technological advancements in pharmaceutical manufacturing could potentially reduce energy usage.
• Shifts in regulatory policies and economic conditions might affect industry growth and energy demands.